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The present study was designed to further eharaeterize the presynaptie musearlnie M1-reeeptor responsible for the 
inhibition of neuragenie eontraetions in the isolated rabbit vas deferens. Eleetrically induced twiteh eontraetions of 
this preparation were inhibited by the M 1-agonist, MeN-A-343, and by some of its analogs: 4-ehloro-phenyl 
derivative> MeN-A-343 > trans-olefinie analog> cis-olefinie analog. The same rank order of potency was obserVed 
for these agonists to raise the blood pressure of pithed rats by stimulation of M 1-receptors in sympathetie ganglia. A 
highly signifieant eorrelation was found between the antimusearinie potencies of atropine, pirenzepine and a series of 9 
antagonists strueturally related to the ganglionie M 1p-receptor selective compounds, hexocyclium and hexahydro-di-
fenidol, to antagonize the MeN-A-343-indueed inhibition of twitch eontraetions in rabbit vas deferens or the 
musearine-indueed depolarization in rat isolated superior eerVieal ganglia. I t is suggested that the presynaptie 
musearlnie receptor that mediates inhibition of neuragenie contraetions in rabbit vas deferens is of the ganglionic 
M1p-type. 
Musearlnie receptor subtypes; Vas deferens (rabbit); Pithed rat; Ganglia (rat); 
Musearlnie aeetyleholine receptor agonists; Musearlnie aeetyleholine receptor antagonists; MeN-A-343 analogs 
1. Introduction 
1t has been shown recently that rabbit vas 
deferens is endowed with musearlnie M1- and 
M 2-reeeptors whieh inversely modulate neuro-
transmission in this preparation (Eltze, 1988a,b). 
Activation of the M1-receptors, e.g. by MeN-A-
343, inhibits neuronally evoked contractions, 
whereas activation of the M 2-receptors, e.g. by 
carbachol, Ieads to a potentiation of electrieally 
induced twitch contractions. McN-A-343 and 
• To whom all correspondence should be addressed: Depart-
ment of Pharmacology, Byk Gulden Pharmaceuticals, D-7750 
Konstanz, F.R.G. 
earbachol have no effeet on tension in unstimu-
lated preparations, whereas eontractions elicited 
by exogenously applied ATP, KCI and noradren-
aline are potentiated by carbachol, but remain 
unaffected by McN-A-343. Therefore, it has been 
postulated that the M1-receptor is located presyn-
aptically, and its activation inhibits transmitter 
(presumably ATP) release, whereas the Mrrecep-
tors are located postsynaptically. 
The postsynaptic M2-reeeptor in rabbit vas de-
ferens is of the cardiac M 2a-type (Eltze, 1988b), 
whereas preliminary studies with analogs of McN-
A-343 suggest that the presynaptic M 1-receptor in 
this organ is pharmacologically similar to the gan-
glionic M1-subtype (Eltze, 1988a). lt has become 
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evident recently that M1-receptors, similar to M 2-
receptors (Eglen and Whiting, 1986; Lambrecht et 
al., 1987; Melchiorre et al., 1987), can be further 
subdivided by functional methods (Lambrecht et 
al., 1987, 1988a). The most primising tools for this 
were the muscarinic antagonists hexahydro-difen-
idol and hexocyclium. The antagonists display 
considerably higher affinity (159- and 63-fold, re-
spectively) for the M1-receptors of rat isolated 
superior cervical ganglia, which mediate depolari-
zation, than for those present in rat hippocampal 
pyramidal cells, which mediate an increase in the 
spike rate (Lambrecht et al., 1988b). Based on 
these antagonist potencies and on the results ob-
tained with the agonist, McN-A-343 (see Discus-
sion), it was proposed that M1-receptors should be 
subclassified into two subtypes (Lambrecht et al., 
1987, 1988b; Mutschier et al., 1987, 1988): M1a 
(hippocampal type) and M lß (ganglionic type). 
To further characterize the presynaptic M1-re-
ceptors in rabbit vas deferens, the affinities of 
hexocyclium, hexahydro-difenidol and several 
MI:N·A-343 (!) 
analogs (fig. 2) for the M1-receptors in this organ 
were compared with those for the receptors in rat 
isolated superior cervical ganglia. We also com-
pared the agonistic potencies of McN-A-343 and 
some analogs (fig. 1) to inhibit neuregenie con-
tractions in rabbit vas deferens with their poten-
cies to raise blood pressure in pithed rats. 
2. Materials and methods 
2.1. lsolated rabbit vas deferens 
Male New Zealand white rabbits (2.5-3.0 kg) 
were killed by exsanguination after the animals 
had been anaesthetized with pentobarbitone 
sodium (60 mgjkg i.v.) and the vasa deferentia 
were removed. The organs were carefully dissected 
free of surrounding tissue and divided into four 
segments, two prostatic portions (1 cm) and two 
epididymal portions (approximately 1.5 cm). Each 
segmentwas folded in two and fixed vertically in 
Fig. 1. Chemical structure of McN-A-343 (1) and analogs 2-6. 
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Fig. 2. Chemical structure of antagonists of the hexocyclium 
(7a) and hexahydro-difenidol (lOa) type. 
a 10 ml water-jacketed organ bath by means of a 
hook-shaped platinum electrode and a cotton 
thread connected to a force-displacement trans-
ducer. A second platinum ring electrode was placed 
at the top of the bathing fluid which consisted of 
(mM): NaCl 118.0, KCl 4.7, CaC1 2 2.5, MgS04 
0.6, KH 2P04 1.2, NaHC03 25.0 and glucose 11.1; 
10-6 M yohimbine was included to block ar 
adrenoceptors. 
The bath solution was maintained at 31° C and 
was continuously bubbled with 95% Üz-5% co2. 
The preparations were preloaded with 0.75 g and 
were left to equilibrate for 30 min before starting 
the continuous field Stimulation (0.5 ms, 30 V, 
0.05 Hz). The contractions of eight preparations, 
run in parallel, were measured isometrically (K-30, 
Hugo Sachs Elektronik) and recorded on multi-
channel recorders (Kipp and Zonen, BD 9). 
235 
2.1.1. Agonist polendes 
Following the stabilization of the contractile 
response to electrical field stimulation, cumulative 
concentration-response curves to musearlnie re-
ceptor agonists were made. The concentration of 
agonistwas increased as soon as a stable response 
to the previous concentration was achieved. The 
apparent potency of an agonist was expressed by 
its -log EC50 value, i.e. the -log of the molar 
concentration that induced a response that was 
50% of the individual maximal effect. 
2.1.2. Antagonist affinities 
Eight preparations were used to determine two 
or three reproducible concentration-response cur-
ves for McN-A-343 (1) (10- 7-2 X 10- 6 M). Subse-
quent curves were then obtained at 45 min inter-
vals, the antagonist being added 15 min before the 
agonist. Schild plots were constructed from the 
dose-ratios of the agonist obtained for three to 
five different antagonist concentrations to esti-
mate the pA 2 value with confidence Iimits and the 
slope of the regression line (Arunlakshana and 
Schild, 1959). The experimental data were fitted 
by a conventional least-squares method (Waud 
and Parker, 1971 ). 
2.2. /so/ated superior cervica/ ganglion of the rat 
Experiments on ganglia were performed as de-
scribed by Brown et al. (1980). Superior cervical 
ganglia were excised from male Sprague-Dawley 
rats (200-300 g) that had been anaesthetized with 
urethane (1.2 gjkg i.p.). Each ganglion was de-
sheathed, suspended vertically in a separate heated 
chamber (36 ° C) and superfused with oxygenated 
(95% 02-5% co2) Krebs solution (1 mljmin) 
which consisted of (mM): NaCl 124.0, KCI 3.0, 
NaHC03 26.0, NaH 2P04 1.25, CaC1 2 2.0, MgCl 2 
2.0 and glucose 10.0. The muscarine-induced de-
polarization (pD2 = 7.4) was recorded differen-
tially, via two calomel electrodes, between the 
ganglion and its postganglionic trunk. The DC 
potentials were amplified by microvoltmeters 
(KEITHLEY 177) and were monitared on a chart 
recorder. To obtain dose-response curves, single 
doses of muscarine were applied at 20-45 min 
intervals, followed by a washout phase until the 
baseline was reached. 
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To determine the antagonistic effects of the 
drugs, dose-response curves for muscarine were 
obtained before and after the addition of an 
antagonist which was allowed to equilibrate for 30 
min. Two or three different concentrations of each 
antagonist were tested and the dose ratios for the 
antagonist-induced parallel shifts of the muscarine 
dose-response curves were estimated. The pA 2 
values were calculated from individual dose ratios 
according to Arunlakshana and Schild (1959). 
2. 3. Pithed rat preparation 
Male Wistar rats (200-350 g) were anaesthe-
tized with pentobarbitone sodium (60 rngjkg i.p.). 
The left jugular vein was cannulated for the ad-
ministration of drugs. Arterial blood pressurewas 
measured from the cannulated right cornrnon 
carotid artery by means of a Statham pressure 
transducer connected to a Hellige amplifier and a 
Rikadenki recorder. After cannulation of the 
trachea, the rats were pithed by introducing a steel 
rod into the spinal canal. The rats were artificially 
respirated with room air by means of a Braun-
Melsungen pump (1 ml/100 g body weight; 60 
strokesjmin). Heparin (150 I.U.jkg i.v.) was given 
to prevent coagulation of the blood. Body temper-
ature was kept at 37 ± 1° C throughout the experi-
ment by means of an overhead heating lamp. 
2.3.1. Experimental protocol 
All agonists were dissolved in saline (0.9% w jv) 
and increasing doses were injected i.v. in a volume 
of 0.1 ml/100 g at 10-15 min intervals until an 
increase in mean arterial pressure of about 80-100 
mm Hg was obtained. As a measure of agonist 
potencies, the doses that caused a blood pressure 
increase of 70 mm Hg (ED 70 values) were de-
termined graphically from the dose-response 
curves. 
2.4. Drugs 
The following drugs were used: heparin sodium 
(Promonta); pentobarbitone sodium (Abott); pi-
renzepine dihydrochloride (Boehringer Ingel-
heim); McN-A-343 (1), 4-[m-chlorophenylcarba-
moyloxy]2-butynyltrimethylammonium chloride 
(RBI, Wayland, USA); Atropine sulfate, d,l-mus-
carine chloride, yohimbine hydrochloride (Sigma). 
McN-A-343 analogs 3 and 4 were kindly donated 
by Dr. W.L. Nelson, University of Washington. 
USA. Compounds 2 and 5-13 were synthesized in 
our laboratories (Lambrecht et al., 1986: 2, 5. 6; 
Zaugg et al., 1958: 7a; Tacke et al., 1988: 7b, 8~ 
Tacke et al., 1985: lOa, tOb; compounds 9 and 
11-13 were synthesized by a method similar to 
that used to prepare the parent compound lOb, 
unpublished results ). 
3. Results 
3.1. Response of the rabbit vas deferens to muscarinic 
agonists 
Electrical field stimulation of the isolated rab-
bit vas deferens elicited individual phasic contrac-
tions of the 'rapid twitch' type, which were repro-
ducible for more than 6 h. McN-A-343 (1) and the 
analogs 2-6 caused a dose-dependent inhibition of 
these twitch responses (fig. 3). However. only 
McN-A-343 (1) and its 4-chloro-phenyl derivative 
2 completely inhibited the twitch contractions at 
high concentrations (fig. 3, table 1). Whereas 2 
proved to be 2.3 times more potent than McN-A-
343 itself, the olefinic derivatives 3 and 4 showed a 
relative potency (compared to McN-A-343) of 0.13 
and 0.52, respectively (fig. 3, table 1). The maxi-
mal inhibition of twitch responses achieved by the 
cis-isomer 3 (36% inhibition) was considerably 
lower than that obtained with the trans-analog 4 
(84% inhibition). The cyclic isoarecolinol deriva-
tives 5 and 6 proved to be weak partial agonists, 
whereby the 4-chloro derivative 6 showed a some-
what greater efficacy. The twitch-inhibiting effect 
of McN-A-343 (1) and analogs 2-6 was readily 
reversible on washing. All agonists tested had no 
effect on the base-line tension of the stimulated or 
quiescent argans at concentrations that markedly 
inhibited the twitch contractions. 
3.2. Effect of muscarinic antagonists in rabbit vas 
deferens 
Atropine, pirenzepine and compounds 7-13 in-
hibited the McN-A-343-induced decrease in con-
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Fig. 3. Concentration-response curves for the inhibitory effects of McN-A-343 (1) and analogs 2-6 on contractions induced by field 
stimulation in the rabbit vas deferens (means±S.D .• n =12-22). 
traction amplitude in the field-stimulated rabbit 
vas deferens. All antagonists shifted the McN-A-
343 dose-response curves to the right in a parallel 
fashion and did not depress the maximal inhibi-
tion caused by the agonist ( data not shown), thus 
indieating competitive antagonism. However, in 
some eases (atropine, 7a, 7b, 10a, 11, 12), the 
slopes of the Schildplots were found tobe signifi-
cantly different from unity (table 2). As shown in 
table 2, the affinities of atropine, pirenzepine and 
TABLE 1 
Potency of McN-A-343 (1) and analogs 2-6 to inhibit twitch 
contractions in the field-stimulated rabbit vas deferens. 
Agonist -log EC50 a Maximal Potency c n 
Mean effect b 
(95% conf. lim.) (mean ± S.D.) 
McN-A-
343 (1) 6.10 (5.53; 6.66) 1.00 1.00 18 
2 6.46 (5.83; 7.10) 1.00 2.3 22 
3 5.22 (4.57; 5.81) 0.36±0.07 0.13 12 
4 5.82 (5.33; 6.31) 0.84±0.08 0.52 14 
5 0.09±0.06 19 
6 :11: 6.0 (-; -) 0.26±0.19 0.79 17 
a Negative log molar concentration producing 50% of the 
maximum response. h Maximal inhibition obtained in relation 
to the maximal effect of McN-A-343 ( = 1.00). c Relative 
potency was calculated from the antilog of differences between 
the -log EC50 values for the respective agonist and for McN-
A-343 which has been arbitrarily assigned a value of 1.00. 
compounds 7-13 for musearlnie M 1-receptors in 
rabbit vas deferens differed by more than two 
orders of magnitude. 
3. 3. Effect of muscarinic antagonists in rat superior 
cervica/ ganglia 
The musearine-induced depolarization of the 
ganglia was antagonized by atropine, pirenzepine 
TABLE 2 
The affinities of the antagonists for musearlnie M1-receptors in 
rabbit vas deferens, related to their inhibition of the McN-A-
343-induced decrease of contraction to field stimulation. The 
pA 2 values (mean with 95% confidence Iimits) and slopes of 
regression lines (mean ± S.D.) were calculated from Schild plots. 
pA2 Slope n 
Atropine 9.16 (8.22; 10.21) a 1.69±0.20 b 12 
Pirenzepine 7.64 (7.13; 8.19) 8 1.22±0.09 16 
7ac 8.99 (8.35; 9.63) 1.44±0.08 b 19 
7bd 8.95 (8.37; 9.53) 1.34±0.23 b 20 
8 7.60 (7.06; 8.14) 1.20±0.11 10 
9 7.76 (7.04; 8.51) 1.07±0.04 12 
10ae 7.75 (7.21; 8.28) 1.22±0.06 b 12 
10br 7.88 (7.42; 8.38) 8 1.09±0.03 19 
11 7.02 (6.37; 7.67) 1.23±0.07 b 12 
12 6.77 (6.15; 7.39) 1.21 ±0.06 b 10 
13 6.72 (6.20; 7.25) 1.06±0.04 11 
a Data taken from Eltze (1988b ). b Slope significantly different 
from unity (P < 0.05). c Hexocyclium. d Sila-hexocyclium. 
e Hexahydro-difenidol. r Hexahydro-sila-difenidol. 
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Fig. 4. Dose-response curves for the inerease in mean arterial pressure (MAP) eaused by MeN-A-343 {1) and analogs 2-6 in the 
pithed rat (means ± S.D., n = 2-7). 
and compounds 7-13. All antagonists produced a 
parallel shift of the muscarine dose-response curve, 
and none of these drugs consistently reduced the 
maximum response to muscarine, obviously indi-
cating competitive antagonism. As shown in table 
3, compound 7-13 showed quite wide variations in 
their affinity for ganglionic muscarinic Mcrecep-
TABLE 3 
The affinities of the antagonists for musearlnie M1-receptors in 
rat superior cervical ganglia, related to their inhibition of the 
muscarine-induced depolarization. The mean pA 2 values and 
their 95% confidence Iimits are given. n indicates the number 
of independent experiments. 
pA2 n 
Atropine 9.1 (9.0; 9.2) 10 
Pirenzepine 8.3 (8.2; 8.4) a 12 
7a b 8.8 (8.5; 9.1) 6 
7bc 9.6 (9.2; 10.0) 12 
8 7.6 (7.3; 7.9) 15 
9 7.7 (7.5; 7.9) 15 
lOa d 7.9 (7.6; 8.2) 6 
lObe 7.3 (7.2; 7.4) 12 
11 6.9 (6.6; 7.2) 8 
12 6.7 (6.4; 7.0) 9 
13 6.4 (6.2; 6.6) 10 
a Data taken from Lambrecht et al. (1988a). b Hexocyclium. 
c Sila-hexocyclium. d Hexahydro-difenidol. e Hexahydro-sila-
difenidol. 
tors. Their pA 2 values differed by up to three 
orders of magnitude. 
3.4. Pressor effects of muscarinic agonists in the 
pithed rat 
The initial mean arterial pressure of the pithed 
rats prior to drug treatment was 50± 9 mm Hg 
(mean ± S.O., n = 22). McN-A-343 (1) and the 
analogs 2-6 caused a dose-dependent rise in the 
mean arterial pressure of the pithed rat (fig. 4). All 
pressor responses were highly sensitive to block-
ade by low doses (100-300 p.gjkg i.v.) of the 
TABLE 4 
The pressor activity of McN-A-343 (1) and analogs 2-6 in 
pithed rats. The -log ED70 values refer to the doses of the 
agonists that cause an increase of 70 mm Hg in the mean 
arterial blood pressure. The values are presented as the means 
with 95% confidence limits (n = 2-7). 
Agonist 
McN-A-343 (1) 
2 
3 
4 
s 
6 
-log ED70 (moljkg i.v.) 
6.27 (6.23; 6.31) 
6.93 (6.73; 7.13) 
5.35 (5.18; 5.52) 
6.04 (5.98; 6.10) 
5.60 (5.31; 5.89) 
5.89 (5.69; 6.09) 
selective M1-receptor antagonist, pirenzepine ( data 
not shown). As a measure of the agonist potencies 
of these compounds, -log ED70 values (ED70 = 
agonist dose corresponding to an increase in mean 
arterial pressure by 70 mm Hg) are listed in table 
4. The 4-chlorophenyl derivative 2 (ED70 = 0.12 
p.moljkg i.v.) was ca. 4.5 times more potent than 
McN-A-343 (ED70 = 0.53 p.moljkg i.v.). Whereas 
the trans-olefinic analog 3 (ED70 = 0.91 p.moljkg 
i.v.) showed a relative potency of about 0.5 (com-
pared to McN-A-343), the cis-olefinic isomer 4 
(ED70 = 4.63 p.moljkg i.v.) was about one order 
of magnitude less potent than the parent com-
pound. The two cyclic derivatives 5 and 6 (ED70 
= 2.77 and 1.36 p.moljkg i.v., respectively) were 
less active than McN-A-343 by a factor of about 5 
and 3.5, respectively. 
3.5. Comparison of agonist potencies in rabbit vas 
deferens and pithed rats 
A significant correlation was found between the 
-log EC50 values of the agonists 1-4 and 6 for the 
inhibition of twitch contractions in the rabbit vas 
deferens (table 1) and the -log ED70 values for 
the rise in mean arterial blood pressure in pithed 
rats (table 4). This correlation (r = 0.95, slope = 
0.75, P < 0.01) is shown in fig. 5. 
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Fig. 5. Comparison between the potencies of McN-A-343 (1), 
analogs 2-4 and 6 to inhibit twitch contractions in rabbit vas 
deferens (-log EC50 , M) and their ability to increase mean 
arterial blood pressure by 70 mm Hg (-log ED70 , moljkg, 
i.v.) in pithed rats. 
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Fig. 6. Comparison between the affinities (pA 2 values) of 
different antimusearinic drugs listed in table 2 and 3 for 
musearlnie M 1-receptors in rabbit vas deferens and rat super-
ior cervical ganglia. 
3. 6. Comparison of antagonist affinities in rabbit vas 
deferens and rat superior cervical ganglia 
A significant correlation (r = 0.94, slope = 0.80, 
P < 0.001; fig. 6) was found between the pA 2 
values for atropine, pirenzepine and compounds 
7-13 obtained in rabbit vas deferens (table 2) and 
those obtained in rat ganglia (table 3). 
4. Discussion 
It has been shown recently (Eltze, 1988a,b) that 
the McN-A-343-induced inhibition of neurogenic 
twitch contractions of the isolated rabbit vas de-
ferens is mediated by Stimulation of presynaptic 
musearlnie heteroreceptors of the M1-type. The 
transmitter released by field stimulation appears 
tobe ATP (Eltze, 1988b; Sneddon et al., 1984). 
Recent evidence suggests that M1-receptors do 
not form a homogeneaus population, but may be 
further subclassified into at least two subtypes: 
M1a- (hippocampal type) and M1ß- (ganglionic 
type) receptors (Lambrecht et al., 1987; 1988b; 
Mutschier et al., 1987; 1988). In the present study, 
we have investigated the actions of a series of 
agonists and antagonists at M1·receptors in the 
isolated rabbit vas deferens and compared these 
actions with their effects at M1-receptors in rat 
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sympathetic ganglia in vitro and in vivo. The 
principal conclusion we draw from these experi-
ments is that the presynaptic M 1-receptors present 
in the rabbit vas deferens are pharmacologically 
very similar to those that mediate depolarization 
in rat sympathetic ganglia. 
McN-A-343 (1) and analogs 2-6 produced a 
concentration-dependent inhibition of twitch con-
tractions in the electrically stimulated rabbit vas 
deferens (fig. 3). However, classical muscarinic 
agonists, such as carbachol or oxotremorine, 
caused a potentiation of twitch contractions via 
activation of postsynaptic M 20- (M 2 cardiac type) 
receptors (Eltze, 1988a,b). As the inhibitory effects 
of McN-A-343 in the rabbit vas deferens have 
been shown to be mediated by the activation of 
presynaptic M1-receptors (Eltze, 1988a,b), these 
findings further support the view that McN-A-343 
and several of its analogs may be regarded as 
selective M 1-receptor stimulants (Hammer and 
Giachetti, 1982; Lambrecht et al., 1986~ Miche-
letti et al., 1988). 
In the pithed rat, McN-A-343 and the analogs 
2-6 produced dose-dependent presser effects (fig. 
4) which are known tobe mediated by Stimulation 
of M 1-receptors in sympathetic ganglia (Hammer 
and Giachetti, 1982; Wesset al., 1984; Lambrecht 
et al., 1986). Interestingly, the agonist potencies of 
compounds 1-6 on the vas deferens and in pithed 
rats were strikingly similar, as measured by their 
EC50 and ED70 values (table 1 and 4), both indi-
vidually and in rank order. A highly significant 
correlation was found between these values (fig. 
5). This implies that the structural and stereo-
chemical demands on compounds 1-6 made by the 
M1-receptors of the vas deferens and sympathetic 
ganglia are similar. 4-Chloro substitution of both 
McN-A-343 (1) and the quaternary isoarecolinol 
derivative 5 led to an increase in potency (com-
pounds 2 and 6). Thus, the 4-chloro McN-A-343 
analog 2 represents the most potent Mcagonist 
known so far. The trans-olefinic analog 4 was 
found to be nearly as potent as McN-A-343 (1) in 
rabbit vas deferens and pithed rats, whereas the 
cis-isomer 3 was about one order of magnitude 
less potent in both preparations. This observation 
might be explained by the fact that certain low 
energy conformations of McN-A-343 can be 
closely approximated by the trans-stereoisomer 4. 
in which the quaternary nitrogen atom and the 
carbamate ether oxygen are about 0.57 nm apart 
in a nearly fully extended conformation (fig. 1). In 
contrast, the cis-isomer 3 cannot be fit to such a 
pattern (Nelson et al., 1973). 
Atropine, pirenzepine and compounds 7-13 
caused a concentration-dependent blockade of 
muscarinic M1-receptors in the rabbit vas deferens 
and rat superior cervical ganglia. The concentra-
tion-response curves for the agonists. McN -A-343 
and muscarine, were shi fted to the right in a 
parallel fashion and the maximum effects of the 
agonists were not depressed. However, in some 
cases the slopes of the Schild plots obtained from 
the rabbit vas deferens experiments were found to 
be significantly greater than unity. Thus, the re-
spective pA 2 values might be underestimated 
slightly. An insufficient equilibration time might 
account for this phenomenon (Kenakin, 1982). 
Compounds 7-13 showed quite wide variations 
in their affinities for the M1-receptors in both vas 
deferens and ganglia (table 2 and 3), their pA 2 
values differing by nearly three orders of magni-
tude. The pA 2 values determined for pirenzepine 
(7.64 and 8.3, respectively) were close to the M 1-
affinities found previously in binding studies with 
calf sympathetic and human stellate ganglia (-log 
Ki = 8.0 and 7.85, respectively) (Giraldo et al., 
1985; Watson et al., 1984). Moreover, the sensitiv-
ities of the M 1-receptors in the rabbit vas deferens 
and in rat superior cervical ganglia to atropine 
and compounds 7-13 were also strikingly similar, 
as shown by their pA 2 values ( table 2 and 3; fig. 
6), again both individually and in rank order. This 
means that the structural demands on the 
antagonists made by the M 1- receptors are very 
similar in both tissues. 
Taking into account that most of the antagonists 
used in this study (7a, 7b, 8, 9, lOa, lOb and 12) 
possess a higher affinity for ganglionic M 1p- (this 
study) than for hippocampal M 10-receptors 
(Lambrecht et al., 1987, 1988b) by factors of 
10-160, these data indicate that the muscarinic 
inhibition of neuregenie contractions in rabbit vas 
deferens is mediated by presynaptic M1p-receptors 
(M1 ganglionic type). This view is further sup-
ported by the observation that the M1-agonist, 
MeN-A-343 (1), is highly potent at ganglionie 
M1p-receptors in vitro (Palaeios et al., 1986) and 
at M1-receptors in the rabbit vas deferens but has 
only very weak, if any, stimulating properties at 
hippocampal M1a-receptors (Gmelin, 1985). 
In eonclusion, we have provided pharmacologi-
eal evidenee that the muscarinie presynaptic het-
eroreceptors in rabbit vas deferens that mediate 
inhibition of neuragenie eontraetions are similar 
to the M1p-receptors in rat sympathetie ganglia in 
terms of agonist potencies and antagonist affini-
ties. Presynaptie M1-receptors have also been 
found in ehieken heart (Jeck et al., 1988), different 
guinea-pig and rat brain areas (Belleroehe and 
Gardiner, 1985; Marehi et al., 1986; Williams and 
Constanti, 1988) as weil as in guinea-pig and rat 
small intestine (Mieheletti et al., 1988; Sehwörer 
and K.ilbinger, 1988). However, it remains to be 
elueidated whether all these presynaptie musearlnie 
reeeptors are pharmacologieally identieal or 
whether they belang to different M1-reeeptor sub-
classes. 
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